Multivariant Covid-19 vaccine booster shows promise, early trial data suggests

The first results of a phase one trial, launched in Manchester in September 2021, reveal the jab has strong levels of neutralising antibodies

Tue, 04 Jan, 2022 - 12:16

Nina Massey, PA Science Correspondent

A Covid vaccine booster aimed at tackling multiple variants shows promise in inducing a comprehensive immune response, early data in Britain suggests.

The first results of a phase one trial, launched in Manchester in September 2021, reveal the jab has strong levels of neutralising antibodies.

CONNECT WITH US TODAY

NEWSLETTERS

NOTIFICATIONS

Be the first to know the latest news and updates

Ireland's Covid review is not public inquiry and 'not here to point fingers', chair says

CSO launches survey to assess impact of Covid-19 pandemic on public

Chairwoman appointed to lead Irish Covid-19 probe

More in this section

Britain to host 35 countries for strait of Hormuz talks on Thursday

Rescuers lose hope for humpback whale stranded in Baltic Sea

Hiker’s dog lost in New Zealand forest rescued after strangers fund search

Coronavirus Place: UK

Rescue workers inspect the scene of an Israeli airstrike as fires burn among damaged vehicles, in Beirut, Lebanon (Hussein Malla/AP)

Attacks persist on Iran and across Middle East as Trump threatens escalation

READ NOW

Multivariant Covid-19 vaccine booster shows promise, early trial data suggests

Continue reading for €5

Attacks persist on Iran and across Middle East as Trump threatens escalation

Latest

Most Read